SCHEMBL23965885

SCHEMBL23965885

Cc1ccccc1-c1ccc2c(c1)c1ccccc1n2-c1ccc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)c(-c2cc(-c3ccccc3C#N)ccc2-n2c3ccccc3c3cc(-c4ccccc4C)ccc32)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 2/20 0.36
AR P10275 1/20 0.33
TRPA1 O75762 1/20 0.33
GABRA1 P14867 5/20 0.33
GABRG2 P18507 5/20 0.33
GABRB3 P28472 5/20 0.33
GABRA2 P47869 4/20 0.33
ALDH1A1 P00352 4/20 0.32
CYP1A2 P05177 3/20 0.32
CYP3A4 P08684 3/20 0.32
HPGD P15428 3/20 0.32
MAPK1 P28482 2/20 0.32
HSD17B10 Q99714 2/20 0.32
CLK4 Q9HAZ1 1/20 0.32
PGR P06401 1/20 0.32
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GABRA5 P31644 3/20 0.32
GABRA3 P34903 3/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21364506 0.97 NR3C1 (0.38) NR3C1ARTRPA1GABRA1GABRG2
SCHEMBL21364332 0.94 NR3C1 (0.37) NR3C1TRPA1GABRA1GABRG2GABRB3
SCHEMBL21364518 0.94 NR3C1 (0.39) NR3C1TRPA1GABRA1GABRG2GABRB3
SCHEMBL21364821 0.93 NR3C1 (0.39) NR3C1TRPA1GABRA1GABRG2GABRB3
SCHEMBL21364819 0.93 NR3C1 (0.40) NR3C1TRPA1GABRA1GABRG2GABRB3
SCHEMBL21364329 0.92 NR3C1 (0.36) NR3C1TRPA1GABRA1GABRG2GABRB3
SCHEMBL21364501 0.92 NR3C1 (0.37) NR3C1TRPA1GABRA1GABRG2GABRB3
SCHEMBL20793936 0.92 AR (0.37) NR3C1ARALDH1A1CYP1A2HPGD
SCHEMBL21364823 0.91 AR (0.35) NR3C1ARTRPA1GABRA1GABRG2
SCHEMBL21364949 0.91 AR (0.36) NR3C1ARTRPA1GABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161836-B2 Organic molecules for optoelectronic devices CYNORA GMBH (DE) 2021-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161836-B2 Organic molecules for optoelectronic devices OR10J3, OR51E2, OCIAD2 NR3C1 4626/4885AR 4698/4885TRPA1 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.